Source: iOne Creative Services / Radio One Digital
A breakthrough treatment for Alzheimer’s Disease is being rationed by the federal government, despite clearance by the FDA. Lindsey Golden, Advocacy Manager for the Alzheimer’s Association – North Carolina, has details on a rally in Charlotte to call for the Centers for Medicare and Medicaid Services to cover lecanemab without barriers.
Listen Here:
